YD Bio Ltd SEC filings YDES

YD Bio Ltd has 80 filings in SEC EDGAR's recent list, going back to Feb 14, 2024. Its latest annual report, Form 20-F, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Sep 1, 2026. The company's fiscal year ends on December 31.

YD Bio Ltd SEC filings
Form Description Filed Period
4 Insider transaction Oct 6, 2026 Sep 30, 2026
4 Insider transaction Oct 6, 2026 Sep 30, 2026
4 Insider transaction Sep 16, 2026 Sep 14, 2026
4 Insider transaction Sep 10, 2026 Sep 9, 2026
4 Insider transaction Sep 8, 2026 Sep 4, 2026
4 Insider transaction Jul 1, 2026 Jun 30, 2026
4 Insider transaction Jul 1, 2026 Jun 30, 2026
3/A Filing Apr 20, 2026 Mar 18, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
3 Initial insider ownership Apr 2, 2026 Mar 18, 2026
3 Initial insider ownership Apr 2, 2026 Mar 18, 2026
3 Initial insider ownership Mar 30, 2026 Mar 18, 2026
3 Initial insider ownership Mar 27, 2026 Mar 18, 2026
3 Initial insider ownership Mar 26, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Dec 16, 2025 —

Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
YDES (Nasdaq), YDESW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Cayman Islands
Headquarters
Taipei City
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
2011674
Former names
True Velocity, Inc./DE (until Jun 21, 2024)

Other Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.